181 related articles for article (PubMed ID: 22396495)
1. Defining NOTCH3 target genes in ovarian cancer.
Chen X; Thiaville MM; Chen L; Stoeck A; Xuan J; Gao M; Shih IeM; Wang TL
Cancer Res; 2012 May; 72(9):2294-303. PubMed ID: 22396495
[TBL] [Abstract][Full Text] [Related]
2. Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.
Park JT; Shih IeM; Wang TL
Cancer Res; 2008 Nov; 68(21):8852-60. PubMed ID: 18974129
[TBL] [Abstract][Full Text] [Related]
3. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
Yamaguchi N; Oyama T; Ito E; Satoh H; Azuma S; Hayashi M; Shimizu K; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Ohwada S; Tatsuta K; Inoue J; Semba K; Watanabe S
Cancer Res; 2008 Mar; 68(6):1881-8. PubMed ID: 18339869
[TBL] [Abstract][Full Text] [Related]
4. Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer.
Chen X; Stoeck A; Lee SJ; Shih IeM; Wang MM; Wang TL
Oncotarget; 2010 Jul; 1(3):210-8. PubMed ID: 20953350
[TBL] [Abstract][Full Text] [Related]
5. Notch3 gene amplification in ovarian cancer.
Park JT; Li M; Nakayama K; Mao TL; Davidson B; Zhang Z; Kurman RJ; Eberhart CG; Shih IeM; Wang TL
Cancer Res; 2006 Jun; 66(12):6312-8. PubMed ID: 16778208
[TBL] [Abstract][Full Text] [Related]
6. Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.
Choi JH; Park JT; Davidson B; Morin PJ; Shih IeM; Wang TL
Cancer Res; 2008 Jul; 68(14):5716-23. PubMed ID: 18632624
[TBL] [Abstract][Full Text] [Related]
7. Notch3 pathway alterations in ovarian cancer.
Hu W; Liu T; Ivan C; Sun Y; Huang J; Mangala LS; Miyake T; Dalton HJ; Pradeep S; Rupaimoole R; Previs RA; Han HD; Bottsford-Miller J; Zand B; Kang Y; Pecot CV; Nick AM; Wu SY; Lee JS; Sehgal V; Ram P; Liu J; Tucker SL; Lopez-Berestein G; Baggerly KA; Coleman RL; Sood AK
Cancer Res; 2014 Jun; 74(12):3282-93. PubMed ID: 24743243
[TBL] [Abstract][Full Text] [Related]
8. Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Jung JG; Stoeck A; Guan B; Wu RC; Zhu H; Blackshaw S; Shih IeM; Wang TL
PLoS Genet; 2014 Oct; 10(10):e1004751. PubMed ID: 25356737
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
10. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
11. Notch3-specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel-resistant ovarian cancer cells.
Kang H; Jeong JY; Song JY; Kim TH; Kim G; Huh JH; Kwon AY; Jung SG; An HJ
Mol Carcinog; 2016 Jul; 55(7):1196-209. PubMed ID: 26207830
[TBL] [Abstract][Full Text] [Related]
12. Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2.
Brown CW; Brodsky AS; Freiman RN
Mol Cancer Res; 2015 Jan; 13(1):78-85. PubMed ID: 25169943
[TBL] [Abstract][Full Text] [Related]
13. NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network.
Ohashi S; Natsuizaka M; Yashiro-Ohtani Y; Kalman RA; Nakagawa M; Wu L; Klein-Szanto AJ; Herlyn M; Diehl JA; Katz JP; Pear WS; Seykora JT; Nakagawa H
Gastroenterology; 2010 Dec; 139(6):2113-23. PubMed ID: 20801121
[TBL] [Abstract][Full Text] [Related]
14. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.
Ohashi S; Natsuizaka M; Naganuma S; Kagawa S; Kimura S; Itoh H; Kalman RA; Nakagawa M; Darling DS; Basu D; Gimotty PA; Klein-Szanto AJ; Diehl JA; Herlyn M; Nakagawa H
Cancer Res; 2011 Nov; 71(21):6836-47. PubMed ID: 21890822
[TBL] [Abstract][Full Text] [Related]
15. Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.
Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama S; Otsuki Y; Miyazaki K
Am J Clin Pathol; 2012 Oct; 138(4):535-44. PubMed ID: 23010708
[TBL] [Abstract][Full Text] [Related]
16. PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion.
Landor SKJ; Santio NM; Eccleshall WB; Paramonov VM; Gagliani EK; Hall D; Jin SB; Dahlström KM; Salminen TA; Rivero-Müller A; Lendahl U; Kovall RA; Koskinen PJ; Sahlgren C
J Biol Chem; 2021; 296():100593. PubMed ID: 33775697
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy.
Indraccolo S; Minuzzo S; Masiero M; Pusceddu I; Persano L; Moserle L; Reboldi A; Favaro E; Mecarozzi M; Di Mario G; Screpanti I; Ponzoni M; Doglioni C; Amadori A
Cancer Res; 2009 Feb; 69(4):1314-23. PubMed ID: 19208840
[TBL] [Abstract][Full Text] [Related]
18. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
19. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
20. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]